MariMed Inc (MRMD) Gross Margin
MariMed Inc (MRMD) currently has a gross margin of 35.6%. Margins are stable over recent quarters. The company is a multi-state cannabis operator (MSO) trading on the OTC.
Current Gross Margin
35.6%
Margin Trend
Stable
Latest Quarter Margin
38.7%
Quarterly Gross Margin
| Period | Revenue | COGS | Gross Profit | Gross Margin |
|---|---|---|---|---|
| FY2026 Q2 | $41.9M | $25.7M | $16.2M | 38.7% |
| FY2026 Q1 | $39.5M | $24.2M | $15.3M | 38.7% |
| FY2025 Q4 | $41.6M | $31.1M | $10.5M | 25.2% |
| FY2025 Q3 | $40.8M | $24.4M | $16.4M | 40.1% |
| FY2025 Q2 | $39.5M | $23.6M | $15.9M | 40.3% |
| FY2025 Q1 | $37.9M | $22.8M | $15.1M | 39.8% |
| FY2024 Q4 | $38.9M | $26.3M | $12.7M | 32.5% |
| FY2024 Q3 | $40.6M | $23.8M | $16.8M | 41.3% |
| FY2024 Q2 | $40.4M | $23.5M | $16.9M | 41.8% |
| FY2024 Q1 | $37.9M | $21.5M | $16.5M | 43.4% |
| FY2023 Q4 | $38.9M | $21.6M | $17.3M | 44.5% |
| FY2023 Q3 | $38.8M | $22.0M | $16.8M | 43.4% |
Frequently Asked Questions
What is MRMD's current gross margin?+
Gross margin for MariMed Inc is calculated as (revenue minus cost of revenue) divided by revenue, expressed as a percentage. It measures how efficiently the company converts sales into gross profit before operating expenses. Higher margins indicate better pricing power or lower production costs.
What is a good gross margin for cannabis companies?+
Cannabis gross margins vary widely by sub-sector. Retailers typically see 40-55%, vertically integrated MSOs 45-60%, and LPs 20-45%. MariMed Inc's margin should be compared to peers in the same sub-sector for meaningful context. Margins above 50% generally indicate strong pricing power.
Why do MRMD's margins change quarter to quarter?+
Gross margin fluctuations for MariMed Inc can result from changes in product mix, pricing pressure from competition, input cost changes (e.g., energy, labor), inventory write-downs, or scaling into new markets where initial costs are higher. Seasonal harvest patterns can also affect margins for cultivators.